Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV.

Szczegóły
Abstrakt

Tytuł:: Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV.
Autorzy:: Sun-Suslow N; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
Saloner R; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.; San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.
Serrano V; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
Umlauf A; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
Morgan EE; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
Ellis RJ; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.; Department of Neurosciences, University of California San Diego, San Diego, San Diego, CA, USA.
Letendre S; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.; Department of Medicine, University of California San Diego, San Diego, CA, USA.
Grant I; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
Heaton RK; Department of Psychiatry, University of California San Diego, San Diego, CA, USA. .; Department of Psychiatry (0603), UCSD School of Medicine, 9500 Gilman Drive, La Jolla, CA, 92093-0603, USA. .
Źródło:: AIDS and behavior [AIDS Behav] 2020 Nov; Vol. 24 (11), pp. 3071-3082.
Typ publikacji:: Comparative Study; Journal Article
Język:: English
Imprint Name(s):: Publication: 2005- : New York, NY : Springer Science + Business Media
Original Publication: New York, NY : Plenum Press, 1997-
MeSH Terms:: Amphetamine-Related Disorders/*complications
HIV Infections/*complications
HIV Infections/*psychology
Methamphetamine/*adverse effects
Sleep Wake Disorders/*psychology
Adult ; Amphetamine-Related Disorders/psychology ; Anti-HIV Agents/therapeutic use ; Cognitive Dysfunction/complications ; Female ; HIV Infections/drug therapy ; HIV Seronegativity ; Humans ; Male ; Methamphetamine/administration & dosage ; Middle Aged ; Neuropsychological Tests ; Self Report ; Sleep ; Sleep Wake Disorders/complications
References:: Clark JP III, Sampair CS, Kofuji P, Nath A, Ding JM. HIV protein, transactivator of transcription, alters circadian rhythms through the light entrainment pathway. Am J Physiol Regul Integr Comp Physiol. 2005;289(3):R656–R662662. (PMID: 15860648)
Wu J, Wu H, Lu C, Guo L, Li P. Self-reported sleep disturbances in HIV-infected people: a meta-analysis of prevalence and moderators. Sleep Med. 2015;16(8):901–7. (PMID: 26188954)
Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111. (PMID: 12531146)
Pellowski JA, Kalichman SC, Matthews KA, Adler N. A pandemic of the poor: social disadvantage and the U.S. HIV epidemic. Am Psychol. 2013;68(4):197–209. (PMID: 236880883700367)
Semple SJ, Patterson TL, Temoshok LR, McCutchan JA, Straits-Troster KA, Chandler JL, et al. Identification of psychobiological stressors among HIV-positive women. HIV Neurobehavioral Research Center (HNRC) Group. Women Health. 1993;20(4):15–36. (PMID: 8171874)
Rondanelli M, Solerte SB, Fioravanti M, Scevola D, Locatelli M, Minoli L, et al. Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection. AIDS Res Hum Retroviruses. 1997;13(14):1243–9. (PMID: 9310292)
Allavena C, Guimard T, Billaud E, De la Tullaye S, Reliquet V, Pineau S, et al. Prevalence and risk factors of sleep disturbance in a large hiv-infected adult population. Aids Behav. 2016;20(2):339–44. (PMID: 26271816)
Passaro RC, Pandhare J, Qian HZ, Dash C. The complex interaction between methamphetamine abuse and HIV-1 pathogenesis. J Neuroimmune Pharmacol. 2015;10(3):477–86. (PMID: 258508934779551)
Bateganya M, Colfax G, Shafer LA, Kityo C, Mugyenyi P, Serwadda D, et al. Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral-naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala. Uganda Aids Patient Care St. 2005;19(11):760–8.
Passaro RC, Ramsey K, Segura ER, Lake JE, Reback CJ, Clark JL, et al. Speed kills: associations between methamphetamine use, HIV infection, tobacco use, and accelerated mortality among gay and bisexual men in Los Angeles, CA 20years after methamphetamine dependence treatment. Drug Alcohol Depen. 2019;195:164–9.
Wang X, Ho WZ. Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission. Life Sci. 2011;88(21–22):972–9. (PMID: 21056582)
Carrico AW, Flentje A, Kober K, Lee S, Hunt P, Riley ED, et al. Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun. 2018;71:108–15. (PMID: 296796376003871)
Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I, et al. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003;188(12):1820–6. (PMID: 14673760)
Fairbairn N, Kerr T, Milloy MJ, Zhang R, Montaner J, Wood E. Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users. Addict Behav. 2011;36(7):762–3. (PMID: 213967843081981)
Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, Franklin DR, et al. Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use. J Addict Med. 2013;7(4):255–63. (PMID: 236486413737384)
Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004;10(1):1–14. (PMID: 14751002)
Chang L, Ernst T, Speck O, Grob CS. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry. 2005;162(2):361–9. (PMID: 156776024899042)
Semple SJ, Patterson TL, Grant I. Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat. 2002;22(3):149–56. (PMID: 12039618)
Kish SJ. Pharmacologic mechanisms of crystal meth. CMAJ. 2008;178(13):1679–82. (PMID: 185598052413312)
London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, et al. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry. 2005;58(10):770–8. (PMID: 16095568)
London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004;61(1):73–84. (PMID: 14706946)
Perez AY, Kirkpatrick MG, Gunderson EW, Marrone G, Silver R, Foltin RW, et al. Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend. 2008;94(1–3):258–62. (PMID: 18078723)
Mahoney JJ III, De La Garza R, Jackson BJ II, Verrico CD, Ho A, Iqbal T, et al. The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res. 2014;219(2):367–71. (PMID: 249511614119803)
Tang J, Liao Y, He H, Deng Q, Zhang G, Qi C, et al. Sleeping problems in Chinese illicit drug dependent subjects. BMC Psychiatry. 2015;15:28. (PMID: 258845734337091)
Lago JA, Kosten TR. Stimulant withdrawal. Addiction. 1994;89(11):1477–81. (PMID: 7841859)
Baberg HT, Nelesen RA, Dimsdale JE. Amphetamine use: return of an old scourge in a consultation psychiatry setting. Am J Psychiatry. 1996;153(6):789–93. (PMID: 8633691)
Reback CJ, Larkins S, Shoptaw S. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. Aids Care. 2003;15(6):775–85. (PMID: 14617499)
World Health Organization. Composite diagnositic international interview (CIDI, version 2.1). Geneva: World Health Organization; 1998.
Beck A, Steer R, Brown G. Manual for beck depression inventory II (BDI-II). San Antonio: Psychology Corporation; 1996.
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–21313. (PMID: 2748771)
Rubinstein ML, Selwyn PA. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19(3):260–5. (PMID: 9803968)
Putnins SI, Griffin ML, Fitzmaurice GM, Dodd DR, Weiss RD. Poor sleep at baseline predicts worse mood outcomes in patients with co-occurring bipolar disorder and substance dependence. J Clin Psychiatry. 2012;73(5):703–8. (PMID: 223137973349805)
Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75(23):2087–96. (PMID: 211353822995535)
Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded halstead reitan battery: demographically adjusted neuropsychological norms for African American and caucasian adults. Lutz: Psychological Assessment Resources, Inc; 2004.
Heaton RK, Taylor MJ, Manly J. Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. Clinical interpretation of the WAIS-III and WMS-III. San Diego: Academic Press; 2003. p. 181–210.
Norman MA, Moore DJ, Taylor M, Franklin D Jr, Cysique L, Ake C, et al. Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol. 2011;33(7):793–804. (PMID: 215478173154384)
Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, et al. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012;26(6):894–908. (PMID: 22708483)
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10(3):317–31. (PMID: 15147590)
Woods SP, Iudicello JE, Moran LM, Carey CL, Dawson MS, Grant I. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology. 2008;22(1):110–7. (PMID: 182111602249562)
Chelune GJ, Heaton RK, Lehman RAW. Neuropsychological and personality correlates of patients' complaints of disability. Advances in clinical neuropsychology, vol 3. New York: Plenum Press; 1986. p. 95–126.
Crooks V, Waller S, Smith T, Hahn TJ. The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol. 1991;46(4):M139–M144144. (PMID: 2071835)
Farivar SS, Cunningham WE, Hays RD. Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes. 2007;5:54. (PMID: 178250962065865)
Dustin DT, Kawachi I, Redline S. The social epidemiology of sleep. New York: Oxford University Press; 2019.
Millar BM, Goedel WC, Duncan DT. Sleep health among sexual and gender minorities. Soc Epidemiol Sleep. 2019:187.
Colfax G, Shoptaw S. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep. 2005;2(4):194–9. (PMID: 16343378)
Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, et al. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med. 1994;56(1):8–17. (PMID: 8197319)
Woods SP, Weber E, Weisz BM, Twamley EW, Grant I, Group HIVNRP. Prospective memory deficits are associated with unemployment in persons living with HIV infection. Rehabil Psychol. 2011;56(1):77–84. (PMID: 214012893264430)
Bhatia MS, Munjal S. Prevalence of depression in people living with HIV/aids undergoing art and factors associated with it. J Clin Diagn Res. 2014;8(10):1–4.
Adinoff B. Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry. 2004;12(6):305–20. (PMID: 157644671920543)
Jiao D, Liu Y, Li X, Liu J, Zhao M. The role of the GABA system in amphetamine-type stimulant use disorders. Front Cell Neurosci. 2015;9:162. (PMID: 259998144419710)
Padgett CL, Lalive AL, Tan KR, Terunuma M, Munoz MB, Pangalos MN, et al. Methamphetamine-evoked depression of GABA(B) receptor signaling in GABA neurons of the VTA. Neuron. 2012;73(5):978–89. (PMID: 224052073560416)
Kamata K, Kameyama T. Effect of chronic administration of methamphetamine on the responsiveness of substantia nigra zona reticulata neurons to GABA or a GABA agonist in rats. Naunyn Schmiedebergs Arch Pharmacol. 1986;334(4):458–62. (PMID: 3821936)
Blumenfeld H. Neuroanatomy through clinical cases. 2nd ed. Sunderland: Sinauer Associates Inc.; 2012.
Association AP. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publication; 2013.
Downing MJ Jr, Houang ST, Scheinmann R, Yoon IS, Chiasson MA, Hirshfield S. Engagement in care, psychological distress, and resilience are associated with sleep quality among HIV-positive gay, bisexual, and other men who have sex with men. Sleep Health. 2016;2(4):322–9. (PMID: 281914915300085)
White JL, Darko DF, Brown SJ, Miller JC, Hayduk R, Kelly T, et al. Early central nervous system response to HIV infection: sleep distortion and cognitive-motor decrements. AIDS. 1995;9(9):1043–50. (PMID: 8527076)
Norman SE, Chediak AD, Freeman C, Kiel M, Mendez A, Duncan R, et al. Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection. Sleep. 1992;15(2):150–5. (PMID: 1579789)
Norman SE, Chediak AD, Kiel M, Cohn MA. Sleep disturbances in HIV-infected homosexual men. AIDS. 1990;4(8):775–81. (PMID: 2261133)
Wiegand M, Moller AA, Schreiber W, Krieg JC, Fuchs D, Wachter H, et al. Nocturnal sleep EEG in patients with HIV infection. Eur Arch Psychiatry Clin Neurosci. 1991;240(3):153–8. (PMID: 1827600)
Ferini-Strambi L, Oldani A, Tirloni G, Zucconi M, Castagna A, Lazzarin A, et al. Slow wave sleep and cyclic alternating pattern (CAP) in HIV-infected asymptomatic men. Sleep. 1995;18(6):446–50. (PMID: 7481416)
Jean-Louis G, Weber KM, Aouizerat BE, Levine AM, Maki PM, Liu C, et al. Insomnia symptoms and HIV infection among participants in the Women's Interagency HIV Study. Sleep. 2012;35(1):131–7. (PMID: 222159273242680)
Lee KA, Gay C, Portillo CJ, Coggins T, Davis H, Pullinger CR, et al. Symptom experience in HIV-infected adults: a function of demographic and clinical characteristics. J Pain Sympt Manag. 2009;38(6):882–93.
Weissman MM, Greenwald S, Niño-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry. 1997;19(4):245–50. (PMID: 9327253)
Thomsen DK, Mehlsen MY, Christensen S, Zachariae R. Rumination—relationship with negative mood and sleep quality. Personality Individ Differ. 2003;34(7):1293–301.
Heitkemper M, Jarrett M, Burr R, Cain K, Landis C, Lentz M, et al. Subjective and objective sleep indices in women with irritable bowel syndrome. Neurogastroenterol Motil. 2005;17(4):523–30. (PMID: 16078941)
Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002;53(3):737–40. (PMID: 12217446)
Gutierrez J, Tedaldi EM, Armon C, Patel V, Hart R, Buchacz K. Sleep disturbances in HIV-infected patients associated with depression and high risk of obstructive sleep apnea. SAGE Open Med. 2019;7:2050312119842268. (PMID: 310014236454647)
Palmer CA, Alfano CA. Sleep and emotion regulation: an organizing, integrative review. Sleep Med Rev. 2017;31:6–16. (PMID: 26899742)
Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA. Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. Sleep. 2013;36(7):1027–32. (PMID: 238143393669060)
O'Brien EM, Mindell JA. Sleep and risk-taking behavior in adolescents. Behav Sleep Med. 2005;3(3):113–33. (PMID: 15984914)
Grant Information:: P50 DA026306 United States DA NIDA NIH HHS; T32 DA031098 United States DA NIDA NIH HHS; F31 AG064989 United States DA NIDA NIH HHS; P30 MH062512 United States MH NIMH NIH HHS; F31 AG064989 United States AG NIA NIH HHS
Contributed Indexing:: Keywords: AIDS; Depression; Stimulant; Substance use
Substance Nomenclature:: 0 (Anti-HIV Agents)
44RAL3456C (Methamphetamine)
Entry Date(s):: Date Created: 20200411 Date Completed: 20200929 Latest Revision: 20211102
Update Code:: 20240105
PubMed Central ID:: PMC7508964
DOI:: 10.1007/s10461-020-02857-7
PMID:: 32274672
: Czasopismo naukowe

Full Text Finder

This study evaluated whether a history of lifetime methamphetamine (MA) use disorder increases risk for poor sleep quality in people with or without HIV infection (HIV+/HIV-). Participants (n = 313) were stratified into four groups based on HIV status and lifetime MA use disorder diagnosis [HIV+/MA+ (n = 84); HIV+/MA- (n = 141); HIV-/MA+ (n = 16); and HIV-/MA- (n = 72)] and compared on global sleep outcomes using the Pittsburgh Sleep Quality Index (PSQI). Significant differences on global sleep were observed between HIV+/MA+ and HIV+/MA- groups, but not between the HIV- groups. Follow-up multiple regression analyses within the HIV+ subgroups examined global sleep scores as a function of MA status and clinical covariates, including those related to HIV disease and demographics. HIV+ individuals with a history of MA use disorder evidenced significantly poorer sleep quality and were more likely to be classified as problematic sleepers than those without a lifetime disorder. This was independent of depressed mood, body mass index, and viral suppression while on treatment. Poorer reported sleep quality among HIV+/MA+ was associated also with multiple adverse functional outcomes, including greater objective cognitive impairment, unemployment, clinical ratings of functional impairment, and self-reported cognitive difficulties, decreased independence in activities of daily living, and poorer overall life quality. Interventions to avoid or curtail MA use in HIV+ individuals may help protect sleep quality and improve functioning.

Informacja